Supernus Pharmaceuticals shares owned by Capital Impact Advisors
Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Capital Impact Advisors
from 13F filings
Historical chart of Capital Impact Advisors investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by Capital Impact Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Supernus Pharmaceuticals by Capital Impact Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $469k | 16k | 30.06 |
| 2023-03-31 | $565k | 16k | 36.23 |
| 2022-12-31 | $795k | 22k | 35.67 |
| 2022-09-30 | $760k | 22k | 34.10 |
| 2022-06-30 | $651k | 23k | 28.91 |
| 2022-03-31 | $837k | 26k | 32.30 |
| 2021-09-30 | $1.3M | 49k | 26.66 |
| 2021-06-30 | $1.5M | 49k | 30.78 |
| 2021-03-31 | $1.3M | 49k | 26.19 |
| 2020-09-30 | $1.7M | 84k | 20.84 |
| 2020-06-30 | $2.0M | 84k | 23.75 |
| 2020-03-31 | $1.5M | 84k | 18.00 |
| 2019-12-31 | $1.9M | 79k | 23.72 |
| 2019-09-30 | $2.1M | 76k | 27.47 |
| 2019-06-30 | $2.0M | 63k | 32.03 |
| 2019-03-31 | $1.4M | 45k | 32.35 |
| 2018-12-31 | $1.4M | 45k | 32.35 |
| 2018-09-30 | $2.0M | 41k | 49.95 |
| 2018-06-30 | $2.2M | 38k | 58.36 |
| 2018-03-31 | $2.0M | 43k | 45.81 |
| 2017-12-31 | $1.2M | 29k | 39.86 |
| 2017-09-30 | $1.2M | 29k | 39.99 |
| 2017-06-30 | $1.3M | 29k | 43.11 |
| 2017-03-31 | $1.3M | 40k | 31.29 |
| 2014-12-31 | $139k | 17k | 8.28 |
| 2014-09-30 | $146k | 17k | 8.69 |
| 2014-06-30 | $184k | 17k | 10.95 |